Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Azithramycine
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Desnica B et al. | Myalgia and swelling of interphalangeal joints as side-effect of prolonged azithromycin therapy in patient with pelvic actinomycosis: case report. | 2007 | Scand. J. Infect. Dis. | pmid:17366044 |
Dakdouki GK et al. | Azithromycin-induced rash in infectious mononucleosis. | 2002 | Scand. J. Infect. Dis. | pmid:12587634 |
Brihmer C et al. | Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women. | 1996 | Scand. J. Infect. Dis. | pmid:8953672 |
Kuzman I et al. | Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. | 1995 | Scand. J. Infect. Dis. | pmid:8588143 |
Batieha A et al. | No advantage of treating acute respiratory tract infections with azithromycin in a placebo-controlled study. | 2002 | Scand. J. Infect. Dis. | pmid:12064684 |
Schönwald S et al. | Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia. | 1994 | Scand. J. Infect. Dis. | pmid:7747094 |
Brandén E et al. | Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection. | 2004 | Scand. J. Infect. Dis. | pmid:15764166 |
Colakoglu S et al. | Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey. | 2006 | Scand. J. Infect. Dis. | pmid:16798693 |
Müller S et al. | Resistance to ampicillin, third-generation cephalosporins, ciprofloxacin, co-trimoxazole and azithromycin in clinical isolates of Salmonella enterica subsp. enterica from Germany: real problem or sporadic circumstance? | 2011 | Scand. J. Infect. Dis. | pmid:21265586 |
Chini P et al. | Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility. | 2012 | Scand. J. Gastroenterol. | pmid:22364597 |
Tabbara KF et al. | Azithromycin prophylaxis and treatment of murine toxoplasmosis. | 2005 | Saudi Med J | pmid:15806206 |
Vafaeimanesh J et al. | Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients. | 2014 | Saudi J Kidney Dis Transpl | pmid:24434382 |
Agah S et al. | Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia. | 2009 Oct-Dec | Saudi J Gastroenterol | pmid:19794266 |
Drake WP et al. | Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. | 2013 | Sarcoidosis Vasc Diffuse Lung Dis | pmid:24284293 |
Elias AF et al. | Typhoid fever in a young immigrant child: a case report and review of the literature. | 2008 | S D Med | pmid:18717293 |
Gologan R et al. | Multiple myeloma in remission complicated by bone marrow granulomas. | 2003 | Rom J Intern Med | pmid:15526516 |
Toledo Junior A et al. | Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil. | 2014 Nov-Dec | Rev. Soc. Bras. Med. Trop. | pmid:25626655 |
Gakiya E et al. | [Experimental infection in mice by Plasmodium berghei: an evidence of antiparasitic action of azithromycin]. | 2001 Mar-Apr | Rev. Soc. Bras. Med. Trop. | pmid:11391444 |
Braz LM et al. | [The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii]. | 1999 Jul-Aug | Rev. Soc. Bras. Med. Trop. | pmid:10495670 |
Sinagra A et al. | The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model. | 2007 Nov-Dec | Rev. Soc. Bras. Med. Trop. | pmid:18200413 |
Lescano SA et al. | [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain]. | 2004 Nov-Dec | Rev. Soc. Bras. Med. Trop. | pmid:15765594 |
Prata A et al. | Efficacy of azithromycin in the treatment of cutaneous leishmaniasis. | 2003 Jan-Feb | Rev. Soc. Bras. Med. Trop. | pmid:12715065 |
Silva-Vergara ML et al. | Azithromycin in the treatment of mucosal leishmaniasis. | 2004 May-Jun | Rev. Inst. Med. Trop. Sao Paulo | pmid:15286825 |
Teixeira AC et al. | Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil. | 2007 Jul-Aug | Rev. Inst. Med. Trop. Sao Paulo | pmid:17823753 |
Teixeira AC et al. | Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil. | 2008 May-Jun | Rev. Inst. Med. Trop. Sao Paulo | pmid:18604416 |
Faucher P and Madelenat P | [Induced abortion]. | 2006 | Rev Prat | pmid:17139871 |
Vaz AP et al. | [Azithromycin as an adjuvant therapy in cryptogenic organizing pneumonia]. | 2011 Jul-Aug | Rev Port Pneumol | pmid:21652172 |
Santos N et al. | QT interval prolongation and extreme bradycardia after a single dose of azithromycin. | 2010 | Rev Port Cardiol | pmid:20391905 |
Bedos JP and Veber B | [Lower respiratory infections: predictive factors of therapeutic response]. | 1996 | Rev Pneumol Clin | pmid:9033917 |
Zuck P | [Efficacy of a 5-day treatment with an azalide (azithromycin) in superinfections of chronic bronchitis]. | 1996 | Rev Pneumol Clin | pmid:9033919 |
DÃaz Sánchez M et al. | [New medications: azithromycin]. | 1993 Jul-Sep | Rev Med Univ Navarra | pmid:8134755 |
Baumgartner JD and Christin L | [2011 news in infections diseases: selected readings]. | 2012 | Rev Med Suisse | pmid:22303737 |
Diezi L et al. | [Pharmacovigilance update]. | 2014 | Rev Med Suisse | pmid:24558915 |
Widikker I and Rochat T | [Pulmonary medicine. Four major papers in 2010-2011]. | 2012 | Rev Med Suisse | pmid:23185822 |
Scheen AJ | [Pharma-clinics. Drug of the month. Azithromycin (Zitromax)]. | 1995 | Rev Med Liege | pmid:7481274 |
Sasseigne G et al. | [Fever and abdominal pain in a 56-year-old woman]. | 2009 | Rev Med Interne | pmid:19815317 |
Diculencu D et al. | [The postantibiotic effect of azithromycin on respiratory pathogens]. | 1998 Jul-Dec | Rev Med Chir Soc Med Nat Iasi | pmid:10756861 |
Diculencu D et al. | [The postantibiotic effect of azithromycin on respiratory pathogens]. | 1996 Jul-Dec | Rev Med Chir Soc Med Nat Iasi | pmid:9455450 |
Eymin G et al. | [Cat-scratch disease. Review of eight adult patients hospitalized for fever or adenopathy]. | 2006 | Rev Med Chil | pmid:17186093 |
Flores S et al. | [Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori]. | 2000 | Rev Med Chil | pmid:11008354 |
Uribe P et al. | [Bacillary angiomatosis]. | 2012 | Rev Med Chil | pmid:23282705 |
Abely M et al. | [National consensus regarding azithromycin use in cystic fibrosis]. | 2015 | Rev Mal Respir | pmid:26003196 |
Silva FM et al. | Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. | 2002 Jan-Feb | Rev Hosp Clin Fac Med Sao Paulo | pmid:12170343 |
López-Fabal F et al. | [In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit]. | 2008 | Rev Esp Quimioter | pmid:18792821 |
Alvarez MP et al. | [Pharmacovigilance study of azithromycin tablets (500 mg) in the treatment of adult patients with respiratory tract infections]. | 2000 | Rev Esp Quimioter | pmid:11086281 |
Toro C et al. | [Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid]. | 2001 | Rev Esp Quimioter | pmid:11704771 |
Gómez J et al. | [Prospective, comparative study (1994-1998) of the influence of short-term prophylactic treatment with azithromycin on patients with advanced COPD]. | 2000 | Rev Esp Quimioter | pmid:11498704 |
Fernández Cuenca F et al. | [In vitro activity of azithromycin against clinical isolates of Acinetobacter baumannii]. | 2003 | Rev Esp Quimioter | pmid:12973458 |
Calvo A et al. | [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae]. | 2001 | Rev Esp Quimioter | pmid:11856980 |
Sánchez F et al. | [Treatment of pneumonia caused by Legionella with azithromycin]. | 1998 | Rev Esp Quimioter | pmid:9795300 |